AnalystsSerge BelangerSerge Belanger's Stock Forecasts
AnalystsSerge Belanger
Analyst Ranking
Top 2%
#55 out of 5200 analysts
Average Return
+19.64%
Win Rate
53%209 out of 396
Risk vs Reward
Poor
Good
Serge Belanger's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Trevi Therapeutics IncTRVI | +426.92% | $2.60 | $13.70 | 2024-12-04 - 2025-12-03 | Buy |
Esperion Therapeutics IncESPR | +299.54% | $0.87 | $3.48 | 2025-05-07 - 2026-02-20 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-06 - 2024-11-05 | Buy |
Arcutis Biotherapeutics IncARQT | +297.44% | $2.34 | $9.30 | 2023-11-06 - 2024-11-05 | Buy |
Trevi Therapeutics IncTRVI | +278.35% | $2.91 | $11.01 | 2024-11-08 - 2025-11-07 | Buy |
Serge Belanger Analyst Color
Get additional color on Serge Belanger's coverage of popular stocks
Serge Belanger's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ocular Therapeutix IncOCUL | 7 | Buy | $18.00 | +131.36% | Maintains | 3 days ago |
Newamsterdam Pharma Co NvNAMS | 11 | Buy | $48.00 | +34.91% | Maintains | 4 days ago |
Viridian Therapeutics IncVRDN | 20 | Buy | $42.00 | +53.06% | Reiterates | 19 days ago |
Arcutis Biotherapeutics IncARQT | 24 | Buy | $31.00 | +21.98% | Maintains | a month ago |
Kalvista Pharmaceuticals IncKALV | 22 | Buy | $35.00 | +121.10% | Maintains | a month ago |
Pacira Biosciences IncPCRX | 28 | Buy | $30.00 | +29.20% | Maintains | a month ago |
Cormedix IncCRMD | 20 | Buy | $15.00 | +113.37% | Maintains | a month ago |
Collegium Pharmaceutical IncCOLL | 23 | Buy | $56.00 | +24.44% | Maintains | a month ago |
Cytokinetics IncCYTK | 26 | Buy | $84.00 | +23.64% | Maintains | 2 months ago |
Oculis Holding AgOCS | 2 | Buy | $36.00 | +23.41% | Reiterates | 3 months ago |
Amphastar Pharmaceuticals IncAMPH | 3 | Buy | $34.00 | +19.17% | Maintains | 4 months ago |
Biocryst Pharmaceuticals IncBCRX | 18 | Buy | $18.00 | +141.61% | Maintains | 4 months ago |
Liquidia CorpLQDA | 33 | Buy | $52.00 | +54.81% | Maintains | 4 months ago |
Xenon Pharmaceuticals IncXENE | 13 | Buy | $55.00 | +30.24% | Reiterates | 4 months ago |
Moonlake ImmunotherapeuticsMLTX | 13 | Buy | $20.00 | +6.55% | Maintains | 5 months ago |
Heron Therapeutics IncHRTX | 21 | Buy | $3.00 | +154.24% | Maintains | 6 months ago |
Trevi Therapeutics IncTRVI | 20 | Buy | $22.00 | +106.77% | Maintains | 6 months ago |
Evolus IncEOLS | 16 | Hold | $22.00 | +403.43% | Downgrades | 7 months ago |
Clearside Biomedical IncCLSDQ | 16 | Hold | $45.00 | +10,875.61% | Downgrades | 7 months ago |
Esperion Therapeutics IncESPR | 20 | Buy | $4.00 | +14.94% | Maintains | 10 months ago |
Verrica Pharmaceuticals IncVRCA | 14 | Hold | $120.00 | N/A | Downgrades | a year ago |
Revance Therapeutics IncRVNC | 16 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Dice Therapeutics IncDICE | 1 | Buy | $56.00 | N/A | Reiterates | 3 years ago |
Tricida IncTCDAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Phasebio Pharmaceuticals IncPHASQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aerie Pharmaceuticals IncAERI | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akebia Therapeutics IncAKBA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Zogenix IncZGNX | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Buy | $18.00 | N/A | Maintains | 5 years ago |
Calcimedica IncCALC | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Hold | N/A | N/A | Downgrades | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.